- Home
- TRMK vs HCM Comparison
TRMK vs HCM Comparison
Compare TRMK & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TRMK | HCM |
|---|---|---|
| Founded | 1889 | 2000 |
| Country | United States | Hong Kong |
| Employees | N/A | 1811 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.6B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | TRMK | HCM |
|---|---|---|
| Price | $44.40 | $14.00 |
| Analyst Decision | Hold | Sell |
| Analyst Count | 2 | 1 |
| Target Price | ★ $44.50 | $13.75 |
| AVG Volume (30 Days) | ★ 309.5K | 37.0K |
| Earning Date | 04-28-2026 | 03-05-2026 |
| Dividend Yield | ★ 2.23% | N/A |
| EPS Growth | ★ 1.93 | N/A |
| EPS | ★ 3.70 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $9.82 | $20.60 |
| Revenue Next Year | $4.86 | $15.62 |
| P/E Ratio | $12.12 | ★ $5.49 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $33.09 | $13.06 |
| 52 Week High | $45.82 | $19.50 |
Technical Indicators
Market Signals| Indicator | TRMK | HCM |
|---|---|---|
| Relative Strength Index (RSI) | 55.33 | 38.24 |
| Support Level | $43.39 | $13.08 |
| Resistance Level | $45.43 | $15.59 |
| Average True Range (ATR) | 0.86 | 0.45 |
| MACD | -0.01 | -0.17 |
| Stochastic Oscillator | 51.50 | 12.75 |
Price Performance
Historical ComparisonAbout TRMK Trustmark Corporation
Trustmark Corp is a bank holding company. Through its subsidiaries, the company operates as a financial services organization providing banking and other financial solutions in Alabama, Florida, Mississippi, Tennessee, and Texas. Its principal products and services include Commercial Banking, Consumer Banking, Mortgage Banking, Insurance, Wealth Management and Trust Services, and others. The company is managed along two operating segments: General Banking and Wealth Management. The General Banking segment, which generates the majority of the revenue, provides all traditional banking products and services, including loan deposits, and also consists of internal operations.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.